Cargando…
A U.S. Government-Coordinated Effort to Leverage Non-Human Primate Data to Facilitate Ebolavirus Vaccine Development
A United States Government (USG) interagency group, the Filovirus Animal Non-Clinical Group (FANG), has been established to support the development of biodefense medical countermeasures (MCMs). As both vaccines and therapeutics are licensed using “non-traditional pathways”, such as the U.S. Food and...
Autores principales: | Taylor, Kimberly L., Lanning, Lynda, Wolfraim, Lawrence, Shrivastava Gales, Sonia, Sico, Colleen, Dowling, William E., Ward, Lucy A., Florence, William C., Nuzum, Edwin, Bryant, Paula R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412622/ https://www.ncbi.nlm.nih.gov/pubmed/36016089 http://dx.doi.org/10.3390/vaccines10081201 |
Ejemplares similares
-
Tracking ebolavirus genomic drift with a resequencing microarray
por: Tiper, Irina, et al.
Publicado: (2022) -
Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates
por: Brannan, Jennifer M., et al.
Publicado: (2019) -
Correction: Tracking ebolavirus genomic drift with a resequencing microarray
por: Tiper, Irina, et al.
Publicado: (2023) -
Ebolavirus Database: Gene and Protein Information Resource for Ebolaviruses
por: Swetha, Rayapadi G., et al.
Publicado: (2016) -
Transcriptional Correlates of Disease Outcome in Anticoagulant-Treated Non-Human Primates Infected with Ebolavirus
por: Garamszegi, Sara, et al.
Publicado: (2014)